Related Experiment Video
Updated: Jan 30, 2026

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
Long non-coding RNA CASC2 upregulates PTEN to suppress pancreatic carcinoma cell metastasis by downregulating miR-21
Hui Zhang1, Xielin Feng1, Mingyi Zhang1
1Department of Hepatopancreatobiliary Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, No. 55, Section 4 South Renmin Road, Chengdu, 610041 China.
Background:
The mechanism of pancreatic cancer metastasis remains poorly understood. Recently, lncRNA CASC2 has been demonstrated to be a tumor suppressor in various types of cancer. This study aimed to explore the mechanism of CASC2 in the regulation of pancreatic cancer metastasis.
Methods:
The expression levels of CASC2 and miR-21 in pancreatic cells were detected by qRT-PCR. Using specific expression vectors, including mimics or shRNA, the expression levels of CASC2, miR-21 and PTEN in pancreatic cells were altered. The association between CASC2, miR-21 and PTEN was detected. Then, cell migration and invasion were assessed using the transwell assay.
Results:
CASC2 expression was downregulated in the pancreatic cancer cell lines CAPAN-1, BxPC-3, JF305, PANC-1 and SW1990 compared with levels in normal human pancreatic HPDE6-C7 cells. CACS2 overexpression inhibited the migration and invasion of PANC-1 cells and significantly inhibited the expression of miR-21 and PTEN. MiR-21 was a direct target of CACS2. The overexpression of miR-21 significantly abolished the antimetastatic effects of CASC2 on PANC-1 cells. Moreover, the downregulation of PTEN significantly abolished the antimetastatic effects of CASC2.
Conclusion:
CASC2 functions as a tumor suppressor in pancreatic cancer cells to inhibit tumor cell migration and invasion. Our work revealed a novel regulatory mechanism of the CASC2/miR-21/PTEN axis that may be important in pancreatic cancer.
Insights
Long non-coding RNA CASC2 suppresses pancreatic cancer metastasis by inhibiting cell migration and invasion. This study reveals the CASC2/miR-21/PTEN pathway as a key regulator in pancreatic cancer progression.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Pancreatic cancer metastasis mechanisms are not fully understood.
- Long non-coding RNA CASC2 acts as a tumor suppressor in various cancers.
- Investigating CASC2's role in pancreatic cancer metastasis is crucial.
Purpose of the Study:
- To explore the mechanism of CASC2 in regulating pancreatic cancer metastasis.
- To elucidate the CASC2/miR-21/PTEN regulatory axis in pancreatic cancer.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to measure CASC2 and miR-21 expression.
- Manipulation of CASC2, miR-21, and PTEN levels using expression vectors and shRNA.
- Transwell assays to assess cell migration and invasion.
Main Results:
- CASC2 expression was significantly downregulated in pancreatic cancer cell lines compared to normal cells.
- CASC2 overexpression inhibited migration and invasion, downregulating miR-21 and PTEN.
- CASC2 directly targets miR-21, and both miR-21 and PTEN are critical mediators of CASC2's antimetastatic effects.
Conclusions:
- CASC2 functions as a tumor suppressor in pancreatic cancer, inhibiting cell migration and invasion.
- The CASC2/miR-21/PTEN axis represents a novel regulatory mechanism in pancreatic cancer.
- This pathway holds potential significance for understanding and targeting pancreatic cancer metastasis.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
RNA Splicing
RNA Polymerase II Accessory Proteins

